Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy.

Franz Sesti Riccardo Pofi Marianna Minnetti Riccardo Pofi Daniele Gianfrilli Andrea M Isidori

Published in: Andrology (2020)

Attempts to demonstrate that TRT damages the cardiovascular system via systematic analysis of the putative mechanisms led to the contradiction of the initial hypothesis. Current evidence indicates that TRT is safe once other comorbidities are addressed.

Keyphrases

replacement therapy
late onset
early onset
smoking cessation
light emitting